» Articles » PMID: 34852704

Inhibition of LC3-associated Phagocytosis in COPD and in Response to Cigarette Smoke

Overview
Publisher Sage Publications
Date 2021 Dec 2
PMID 34852704
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction/rationale: In chronic obstructive pulmonary disease (COPD), defective macrophage phagocytic clearance of cells undergoing apoptosis by efferocytosis may lead to secondary necrosis of the uncleared cells and contribute to airway inflammation. The precise mechanisms for this phenomenon remain unknown. LC3-associated phagocytosis (LAP) is indispensable for effective efferocytosis. We hypothesized that cigarette smoke inhibits the regulators of LAP pathway, potentially contributing to the chronic airways inflammation associated with COPD.

Methods: Bronchoalveolar (BAL)-derived alveolar macrophages, lung tissue macrophages obtained from lung resection surgery, and monocyte-derived macrophages (MDM) were prepared from COPD patients and control participants. Lung/airway samples from mice chronically exposed to cigarette smoke were also investigated. Differentiated THP-1 cells were exposed to cigarette smoke extract (CSE). The LAP pathway including Rubicon, as an essential regulator of LAP, efferocytosis and inflammation was examined using western blot, ELISA, flow cytometry, and/or immunofluorescence.

Results: Rubicon was significantly depleted in COPD alveolar macrophages compared with non-COPD control macrophages. Rubicon protein in alveolar macrophages of cigarette smoke-exposed mice and cigarette smoke-exposed MDM and THP-1 was decreased with a concomitant impairment of efferocytosis. We also noted increased expression of LC3 which is critical for LAP pathway in COPD and THP-1 macrophages. Furthermore, THP-1 macrophages exposed to cigarette smoke extract exhibited higher levels of other key components of LAP pathway including Atg5 and TIM-4. There was a strong positive correlation between Rubicon protein expression and efferocytosis.

Conclusion: LAP is a requisite for effective efferocytosis and an appropriate inflammatory response, which is impaired by Rubicon deficiency. Our findings suggest dysregulated LAP due to reduced Rubicon as a result of CSE exposure. This phenomenon could lead to a failure of macrophages to effectively process phagosomes containing apoptotic cells during efferocytosis. Restoring Rubicon protein expression has unrecognized therapeutic potential in the context of disease-related modifications caused by exposure to cigarette smoke.

Citing Articles

IRG1/itaconate enhances efferocytosis by activating Nrf2-TIM4 signaling pathway to alleviate con A induced autoimmune liver injury.

Zeng L, Wang Y, Huang Y, Yang W, Zhou P, Wan Y Cell Commun Signal. 2025; 23(1):63.

PMID: 39910615 PMC: 11796036. DOI: 10.1186/s12964-025-02075-5.


Phytochemical-mediated efferocytosis and autophagy in inflammation control.

Vafadar A, Tajbakhsh A, Hosseinpour-Soleimani F, Savardshtaki A, Hashempur M Cell Death Discov. 2024; 10(1):493.

PMID: 39695119 PMC: 11655565. DOI: 10.1038/s41420-024-02254-2.


The Current Molecular and Cellular Landscape of Chronic Obstructive Pulmonary Disease (COPD): A Review of Therapies and Efforts towards Personalized Treatment.

Farrell L, ORourke M, Padula M, Souza-Fonseca-Guimaraes F, Caramori G, Wark P Proteomes. 2024; 12(3).

PMID: 39189263 PMC: 11348234. DOI: 10.3390/proteomes12030023.


Clearing the Path: Exploring Apoptotic Cell Clearance in Inflammatory and Autoimmune Disorders for Therapeutic Advancements.

Ghorbanzadeh S, Khojini J, Abouali R, Alimardan S, Zahedi M, Tahershamsi Z Mol Biotechnol. 2024; .

PMID: 38935260 DOI: 10.1007/s12033-024-01222-6.


Pollutants, microbiota and immune system: frenemies within the gut.

Rio P, Gasbarrini A, Gambassi G, Cianci R Front Public Health. 2024; 12:1285186.

PMID: 38799688 PMC: 11116734. DOI: 10.3389/fpubh.2024.1285186.


References
1.
Morimoto K, Janssen W, Fessler M, McPhillips K, Borges V, Bowler R . Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol. 2006; 176(12):7657-65. DOI: 10.4049/jimmunol.176.12.7657. View

2.
Hodge S, Matthews G, Mukaro V, Ahern J, Shivam A, Hodge G . Cigarette smoke-induced changes to alveolar macrophage phenotype and function are improved by treatment with procysteine. Am J Respir Cell Mol Biol. 2010; 44(5):673-81. DOI: 10.1165/rcmb.2009-0459OC. View

3.
Wang Y, Luo G, Chen J, Jiang R, Zhu J, Hu N . Cigarette smoke attenuates phagocytic ability of macrophages through down-regulating Milk fat globule-EGF factor 8 (MFG-E8) expressions. Sci Rep. 2017; 7:42642. PMC: 5307389. DOI: 10.1038/srep42642. View

4.
Li M, Yu D, Williams K, Liu M . Tobacco smoke induces the generation of procoagulant microvesicles from human monocytes/macrophages. Arterioscler Thromb Vasc Biol. 2010; 30(9):1818-24. PMC: 2939448. DOI: 10.1161/ATVBAHA.110.209577. View

5.
Zhang W, Zhao J, Wang R, Jiang M, Ye Q, Smith A . Macrophages reprogram after ischemic stroke and promote efferocytosis and inflammation resolution in the mouse brain. CNS Neurosci Ther. 2019; 25(12):1329-1342. PMC: 6887920. DOI: 10.1111/cns.13256. View